Kinetics and Mechanisms of Racemization: 5‐Substituted Hydantoins (= Imidazolidine‐2,4‐diones) as Models of Chiral Drugs

Abstract

Listen

Translate article

AbstractA chiral center in a drug molecule increases the complexity of synthetic, metabolic, pharmacological, and clinical studies, an additional problem being a possible lack of configurational stability. Here, we report detailed kinetic and mechanistic studies on the deuteration and racemization of seven 5‐monosubstituted hydantions (= imidazolidine‐2,4‐diones) used as model compounds. Using 1H‐NMR and chiral RP‐HPLC, rates of reaction and thermodynamic parameters of activation were determined for the reactions of deuteration and racemization. Energies of deprotonation were obtained by molecular‐orbital calculations performed at the AM1 level. It is demonstrated that the deuteration and racemization of 5‐monosubstituted hydantoins follow general‐base catalysis. The identical (within experimental errors) activation energies of deuteration and racemization indicate that the two reactions share a common reaction mechanism. The fact that the pseudo‐first‐order rate constants of deuteration are about half of those of racemization suggests that deuteration occurs with inversion of configuration. Very large differences in reaction rates were observed between the seven compounds, indicating the marked influence of substituents on chiral stability. These results, together with the small isotope effects observed, and the comparison between experimental activation energies and calculated energies of deprotonation, suggest a SE2 push‐pull mechanism for the racemization of 5‐monosubstituted hydantoins.